Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight

lorundrostatMZE829rilparencelNeutral

AI Analysis

Summary

DelveInsight market analysis highlights five emerging therapies for chronic kidney disease expected to evolve by 2036, including lorundrostat, MZE829, and rilparencel across multiple modalities.

Importance:2/10

Sentiment:

0.00

chronic kidney diseaseemerging therapiespipeline analysisendothelin receptor antagonistsaldosterone synthase inhibitorsAPOL1 inhibitorscell therapy

Related Companies

$DHCNL

Read the original article

Published by PR Newswire Pharma on September 24, 2026 2:31 PM

Read Original